2007 APS March Meeting
Volume 52, Number 1
Monday–Friday, March 5–9, 2007;
Denver, Colorado
Session H19: Focus Session: New Frontiers in Imaging IV
8:00 AM–10:48 AM,
Tuesday, March 6, 2007
Colorado Convention Center
Room: 104
Sponsoring
Unit:
DCP
Chair: Jeffrey Reimer, University of California, Berkeley
Abstract ID: BAPS.2007.MAR.H19.1
Abstract: H19.00001 : Molecular Dynamics Underlie the Nature of MRI Signals: The NMR Shutter-Speed
8:00 AM–8:36 AM
Preview Abstract
Abstract
Author:
Charles S. Springer, Jr.
(Oregon Health \& Science University)
Motions of the spin-bearing molecules can have profound effects
on the very
nature (the exponentiality) of the macroscopic NMR signal.
Quantitative
mechanistic protocols often involve varying the equilibrium
molecular
kinetics (usually by temperature~change) relative to the ``NMR
time-scale''
(SS$^{-1})$, usually ill-defined as the absolute difference of
resonance
frequencies [$\vert \Delta \omega \vert $] in sites between which
spins are exchanged.
This holds true for the equilibrium water molecule exchange
between tissue
compartments and distinct populations. However, \textit{in vivo}
studies must [by
regulation] be isothermal, and the tissue $^{1}$H$_{2}$O MRI
signals remain
essentially isochronous [$\Delta \omega $ = 0].
In NMR, an equilibrium process is manifest in the context of its
``exchange
condition.'' It only ``appears'' to be fast or slow by comparison
of its
actual rate~constant with its \textit{system}
``shutter{\-}speed'' (SS). [A~nonzero $\Delta
\omega $ is the first, but not only, SS: its~dimension is reciprocal
time.] The process kinetics can be measured only if its NMR
condition is
varied at least partway between the fast- and slow exchange
limits. In an
isothermal study with no catalyst, this can be accomplished only
by varying
the pertinent SS.
An MRI contrast reagent (CR) increases the laboratory frame
$^{1}$H$_{2}$O
relaxation rate constant, R$_{i}$ [$\equiv $~(T$_{i})^{-1}$; i =
1,2]. For
an isochronous exchange process, the SS is the intrinsic $\vert
\Delta
$R$_{i}\vert $ for the sites. In~quantitative
dynamic-contrast-enhanced
(DCE) studies, analytical pharmacokinetic modeling is
accomplished on
region-of-interest (ROI) or pixel by pixel $^{1}$H$_{2}$O signal
time-courses following bolus CR injections. Accounting for the
equilibrium
transendothelial and transcytolemmal water interchange processes (a
three-site exchange situation) is crucial for modeling accuracy: the
relevant SS values vary during the CR bolus passage. This is so
for DCE
studies of cancer, multiple sclerosis, and myocardial blood flow
variation.
It is necessary for the successful discrimination of malignant
and benign
breast and prostate lesions.
One can expect a SS for almost any NMR experiment. This includes
diffusion
weighted and rotating-frame longitudinal relaxation of\textit{ in
vivo} $^{1}$H$_{2}$O
signals. In~these latter cases, the pertinent SS can be
manipulated solely
by adjustment of pulse sequence parameters, leading to completely
non-invasive protocols.
To cite this abstract, use the following reference: http://meetings.aps.org/link/BAPS.2007.MAR.H19.1